Cargando…

Effect of Pemafibrate on Serum Creatinine in Patients with Chronic Kidney Disease

INTRODUCTION: Fibrates are recommended not to be used for the treatment of hypertriglyceridemia in patients with chronic kidney disease (CKD) based on clinical practice guidelines. The major reason for the negative suggestion is the elevation of serum creatinine and rhabdomyolysis by fibrates. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imai, Enyu, Imai, Atsuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Medical Association 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358292/ https://www.ncbi.nlm.nih.gov/pubmed/35992291 http://dx.doi.org/10.31662/jmaj.2021-0212

Ejemplares similares

Salivary Creatinine Estimation as an Alternative to Serum Creatinine in Chronic Kidney Disease Patients
por: Venkatapathy, Ramesh, et al.
Publicado: (2014)

Association between serum Na–Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study
por: Maruta, Yuichi, et al.
Publicado: (2018)

Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study
por: Iwasaki, Masako, et al.
Publicado: (2023)

Correlation of Ultrasonographic Parameters with Serum Creatinine in Chronic Kidney Disease
por: Siddappa, Jagdeesh K., et al.
Publicado: (2013)

Effects of Carperitide on Contrast-Induced Acute Kidney Injury with a Minimum Volume of Contrast in Chronic Kidney Disease Patients
por: Okumura, Naoki, et al.
Publicado: (2012)

RETRACTED ARTICLE: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease
por: Nitta, Kosaku, et al.
Publicado: (2013)

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
por: Tanaka, Tetsuhiro, et al.
Publicado: (2018)

Analysis of 2897 hospitalization events for patients with chronic kidney disease: results from CKD-JAC study
por: Iimuro, Satoshi, et al.
Publicado: (2019)

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study
por: Nitta, Kosaku, et al.
Publicado: (2018)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
por: An, Jung Nam, et al.
Publicado: (2022)

Comparison of Serum Concentrations of Symmetric Dimethylarginine and Creatinine as Kidney Function Biomarkers in Cats with Chronic Kidney Disease
por: Hall, J.A., et al.
Publicado: (2014)

The Serum Uric Acid to Serum Creatinine Ratio is an Independent Risk Factor for Diabetic Kidney Disease
por: Chen, Li, et al.
Publicado: (2022)

Role of Ultrasound in the Diagnosis of Chronic Kidney Disease and its Correlation with Serum Creatinine Level
por: Ahmed, Shakeel, et al.
Publicado: (2019)

Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease
por: Hall, J.A., et al.
Publicado: (2016)

Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Inaguma, Daijo, et al.
Publicado: (2016)

Effect of serum creatinine difference between the Jaffe and the enzymatic method on kidney disease detection and staging
por: Boss, Kristina, et al.
Publicado: (2023)

Cystatin C is Better than Serum Creatinine for Estimating Glomerular Filtration Rate to Detect Osteopenia in Chronic Kidney Disease Patients
por: Kwon, Young Eun, et al.
Publicado: (2017)

Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease
por: Lin, Yu-Li, et al.
Publicado: (2021)

Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study
por: Schneider, Cornelia, et al.
Publicado: (2016)

Effects of Pemafibrate in Patients with Stroke and Hypertriglyceridemia: Baseline Cerebral Artery Diseases and 3-Month Laboratory Outcomes
por: Hoshino, Takao, et al.
Publicado: (2022)

Salivary creatinine as a diagnostic tool for evaluating patients with chronic kidney disease
por: Temilola, Dada Oluwaseyi, et al.
Publicado: (2019)

Relationship among Serum Creatinine, Serum Gastrin, Calcium‐phosphorus Product, and Uremic Gastropathy in Cats with Chronic Kidney Disease
por: McLeland, S.M., et al.
Publicado: (2014)

Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial
por: Maruyama, Shoichi, et al.
Publicado: (2023)

Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease
por: Shinozaki, Satoshi, et al.
Publicado: (2020)

Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stones
por: Hall, Jean A., et al.
Publicado: (2017)

Joint modeling on serum creatinine and time to end stage of renal disease for chronic kidney disease patients under treatment at the University of Gondar Referral Hospital
por: Belay, Samson, et al.
Publicado: (2023)

Pemafibrate therapy for non-alcoholic fatty liver disease is more effective in lean patients than obese patients
por: Shinozaki, Satoshi, et al.
Publicado: (2022)

Decrease in Urinary Creatinine Excretion in Early Stage Chronic Kidney Disease
por: Tynkevich, Elena, et al.
Publicado: (2014)

Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine
por: Young, Tramaine, et al.
Publicado: (2017)

Half Dose Once-Daily Pemafibrate Effectively Improved Hypertriglyceridemia in Real Practice
por: Iitake, Chie, et al.
Publicado: (2019)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022)

Patient Selection for Pemafibrate Therapy to Prevent Adverse Cardiovascular Events
por: Izumida, Toshihide, et al.
Publicado: (2022)

Association between Urinary Creatinine Excretion and Hypothyroidism in Patients with Chronic Kidney Disease
por: Matsuoka-Uchiyama, Natsumi, et al.
Publicado: (2023)

Impact of Gate 99mTc DTPA GFR, Serum Creatinine and Urea in Diagnosis of Patients with Chronic Kidney Failure
por: Miftari, Rame, et al.
Publicado: (2017)

Can salivary creatinine and urea levels be used to diagnose chronic kidney disease in children as accurately as serum creatinine and urea levels? A case–control study
por: Renda, Rahime
Publicado: (2017)

Creatinine- and Cystatin C-Based Incidence of Chronic Kidney Disease and Acute Kidney Disease in AKI Survivors
por: Rimes-Stigare, Claire, et al.
Publicado: (2018)

Efficacy and Safety of Low-Dose Pemafibrate Therapy for Hypertriglyceridemia in Patients with Type 2 Diabetes
por: Bando, Hidenori, et al.
Publicado: (2021)

A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With Hypertriglyceridemia
por: Katsuyama, Hisayuki, et al.
Publicado: (2023)

Changes in Mortality According to Creatinine/Cystatin C Ratio in Chronic Kidney Disease and Non-chronic Kidney Disease Patients
por: Hwang, Jeong Ah, et al.
Publicado: (2022)

Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
por: Aldenbratt, Annika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sjj9g8uodipcihd9usddp9sn9c